Cargando…

Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia

Schizophrenia is a mental disorder that is characterized by various abnormal symptoms. Previous studies indicate decreased expression of phospholipase C-β1 (PLC-β1) in the brains of patients with schizophrenia. PLC-β1-null (PLC-β1(−/−)) mice exhibit multiple endophenotypes of schizophrenia. Furtherm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seong-Wook, Cho, Taesup, Lee, Sukchan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648068/ https://www.ncbi.nlm.nih.gov/pubmed/26635636 http://dx.doi.org/10.3389/fpsyt.2015.00159

Ejemplares similares

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?
por: Bygrave, Alexei M., et al.
Publicado: (2019)

NMDAR Hypofunction Animal Models of Schizophrenia
por: Lee, Gloria, et al.
Publicado: (2019)

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia
por: Wu, Qiongqiong, et al.
Publicado: (2021)

The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia
por: Chen, Cynthia Yi-An, et al.
Publicado: (2021)

Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia
por: Kehrer, Colin, et al.
Publicado: (2008)

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
por: Snyder, Melissa A., et al.
Publicado: (2013)

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Nakazawa, Kazu, et al.
Publicado: (2017)

Molecular Basis of GABA Hypofunction in Adolescent Schizophrenia-Like Animals
por: Wang, Xiaodan, et al.
Publicado: (2021)

mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia
por: Wang, Hoau-Yan, et al.
Publicado: (2018)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

High-Frequency Neuronal Oscillatory Abnormalities in the Phospholipase C-β1 Knockout Mouse Model of Schizophrenia
por: Hudson, Matthew R, et al.
Publicado: (2018)

Physical Functional Capacity and C-Reactive Protein in Schizophrenia
por: Szortyka, Michele Fonseca Vieira, et al.
Publicado: (2016)

The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2014)

Altered Cortical Functional Networks in Patients With Schizophrenia and Bipolar Disorder: A Resting-State Electroencephalographic Study
por: Kim, Sungkean, et al.
Publicado: (2020)

Mechanisms of Auditory Verbal Hallucination in Schizophrenia
por: Cho, Raymond, et al.
Publicado: (2013)

Association of Depression With Functional Mobility in Schizophrenia
por: Kim, Jiheon, et al.
Publicado: (2020)

Commentary: Physical Functional Capacity and C-Reactive Protein in Schizophrenia
por: Elliesen, Ruth, et al.
Publicado: (2018)

Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes
por: Rompala, Gregory R., et al.
Publicado: (2013)

Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction
por: Nakao, Kazuhito, et al.
Publicado: (2019)

Aberrant maturation and connectivity of prefrontal cortex in schizophrenia – contribution of NMDA receptor development and hypofunction
por: Gao, Wen-Jun, et al.
Publicado: (2022)

Is Inner Speech the Basis of Auditory Verbal Hallucination in Schizophrenia?
por: Cho, Raymond, et al.
Publicado: (2014)

Altered Neuroanatomical Signatures of Patients With Treatment-Resistant Schizophrenia Compared to Patients With Early-Stage Schizophrenia and Healthy Controls
por: Liu, Congcong, et al.
Publicado: (2022)

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia
por: Jun, Rachel, et al.
Publicado: (2022)

Disrupted-in-Schizophrenia 1 (DISC1) Overexpression and Juvenile Immune Activation Cause Sex-Specific Schizophrenia-Related Psychopathology in Rats
por: Uzuneser, Taygun C., et al.
Publicado: (2019)

C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
por: Fond, Guillaume, et al.
Publicado: (2018)

Association of Serotonin(2c) Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia
por: Li, Jiang, et al.
Publicado: (2019)

A rare case of schizophrenia coexistence with antiphospholipid syndrome, β-thalassemia, and monoclonal gammopathy of undetermined significance
por: Jin, Yingming, et al.
Publicado: (2023)

Diagnosing vestibular hypofunction: an update
por: Starkov, Dmitrii, et al.
Publicado: (2020)

Abnormal maternal behavior in mice lacking phospholipase Cβ1
por: Kim, Hea-jin, et al.
Publicado: (2022)

Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
por: Ibarra-Lecue, Inés, et al.
Publicado: (2020)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020)

Effects of an Audiovisual Emotion Perception Training for Schizophrenia: A Preliminary Study
por: Jeong, Ji Woon, et al.
Publicado: (2021)

Machine Learning-Based Electroencephalographic Phenotypes of Schizophrenia and Major Depressive Disorder
por: Jang, Kuk-In, et al.
Publicado: (2021)

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
por: Kinon, Bruce J.
Publicado: (2019)

The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia
por: Li, Hongna, et al.
Publicado: (2022)

Deletion of Phospholipase C β1 in the Thalamic Reticular Nucleus Induces Absence Seizures
por: Chang, Bomi, et al.
Publicado: (2022)

Distinct Differences in Emotional Recognition According to Severity of Psychotic Symptoms in Early-Stage Schizophrenia
por: Won, Seunghee, et al.
Publicado: (2019)

Executive Functioning in Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2013)

Editorial: Smoking and Schizophrenia
por: Castle, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5rhqmlo7t3bv4ea078lqshvk6k